Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,169.75 -21.75 (-0.52%) Dow Futures
34,097.00 0.00 (0.00%) Nasdaq Futures
12,652.50 -194.25 (-1.51%) Russell 2000 Futures
2,007.50 -0.40 (-0.02%) Crude Oil
76.07 +0.19 (+0.25%) Gold
1,931.30 +0.50 (+0.03%)
At close: 04:00PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 84.32 |
| Open | 84.61 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 3000 |
| Day's Range | 84.26 - 86.38 |
| 52 Week Range | 44.98 - 91.39 |
| Volume | |
| Avg. Volume | 444,981 |
| Market Cap | 4.414B |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | 40.74 |
| EPS (TTM) | 2.12 |
| Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 86.57 |
- Zacks
Analysts Estimate Phibro Animal Health (PAHC) to Report a Decline in Earnings: What to Look Out for
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Looking for a Growth Stock? 3 Reasons Why Haemonetics (HAE) is a Solid Choice
Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Haemonetics (HAE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
